Europe Autoimmune Disease Therapeutics Market (2019-2025)
The Europe Autoimmune Disease Therapeutics Market would witness market growth of 3.94% CAGR during the forecast period (2019–2025).
Epigenetic pathways play a key role in the growth and function of the immune system. A growing body of research has been released over the past century attempting to clarify the correlation between epigenetic modifications and the growth of autoimmune disorders. Epigenetic changes like histone modifications, DNA methylation, and non-coding RNAs, are primarily engaged in the pathogenesis of autoimmune diseases by controlling gene expression. Significant epigenetic changes have occurred during the growth of the most common human autoimmune diseases. These changes include systemic lupus erythematosus (SLE), systemic sclerosis (SSc), rheumatoid arthritis (RA), Sjogren's syndrome (SS), autoimmune thyroid illnesses (AITD), and type 1 diabetes (T1D). These targeted at offering fresh insights into the pathogenesis of autoimmune diseases and the chance of developing new therapeutic strategies that target the epigenome.
Based on Indication, the market is segmented into Rheumatic Disease, Diabetes, Multiple Sclerosis, Inflammatory Bowel Disease, and Other Indications. Based on Drug Class, the market is segmented into Anti-Inflammatory, Anti-Hyperglycemics, NSAIDs (Nonsteroidal anti-inflammatory drugs), Interferons and Other Drugs. Based on the Distribution Channel, the market is segmented into Hospital Pharmacy, Online and Retail Pharmacies & Drug Stores. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include ABBOTT Laboratories, Bio-Rad Laboratories, Inc., Johnson and Johnson, GlaxoSmithKline PLC (GSK), Pfizer, Inc., Merck & Co., Inc., Bayer AG, AbbVie, Inc., Amgen, Inc. and Novartis AG.
Scope of the Study
Market Segmentation:
By Indication
Epigenetic pathways play a key role in the growth and function of the immune system. A growing body of research has been released over the past century attempting to clarify the correlation between epigenetic modifications and the growth of autoimmune disorders. Epigenetic changes like histone modifications, DNA methylation, and non-coding RNAs, are primarily engaged in the pathogenesis of autoimmune diseases by controlling gene expression. Significant epigenetic changes have occurred during the growth of the most common human autoimmune diseases. These changes include systemic lupus erythematosus (SLE), systemic sclerosis (SSc), rheumatoid arthritis (RA), Sjogren's syndrome (SS), autoimmune thyroid illnesses (AITD), and type 1 diabetes (T1D). These targeted at offering fresh insights into the pathogenesis of autoimmune diseases and the chance of developing new therapeutic strategies that target the epigenome.
Based on Indication, the market is segmented into Rheumatic Disease, Diabetes, Multiple Sclerosis, Inflammatory Bowel Disease, and Other Indications. Based on Drug Class, the market is segmented into Anti-Inflammatory, Anti-Hyperglycemics, NSAIDs (Nonsteroidal anti-inflammatory drugs), Interferons and Other Drugs. Based on the Distribution Channel, the market is segmented into Hospital Pharmacy, Online and Retail Pharmacies & Drug Stores. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include ABBOTT Laboratories, Bio-Rad Laboratories, Inc., Johnson and Johnson, GlaxoSmithKline PLC (GSK), Pfizer, Inc., Merck & Co., Inc., Bayer AG, AbbVie, Inc., Amgen, Inc. and Novartis AG.
Scope of the Study
Market Segmentation:
By Indication
- Rheumatic Disease
- Diabetes
- Multiple Sclerosis
- Inflammatory Bowel Disease
- Other Indications
- Anti-Inflammatory
- Anti-Hyperglycemics
- NSAIDs
- Interferons
- Other Drugs
- Hospital Pharmacy
- Online
- Retail Pharmacies and Drug Stores
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
- ABBOTT Laboratories
- Bio-Rad Laboratories, Inc.
- Johnson and Johnson
- GlaxoSmithKline PLC (GSK)
- Pfizer, Inc.
- Merck & Co., Inc.
- Bayer AG
- AbbVie, Inc.
- Amgen, Inc.
- Novartis AG
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
CHAPTER 1. MARKET SCOPE & METHODOLOGY
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Autoimmune Disease Therapeutics Market, by Indication
1.4.2 Europe Autoimmune Disease Therapeutics Market, by Drug Class
1.4.3 Europe Autoimmune Disease Therapeutics Market, by Distribution Channel
1.4.4 Global Autoimmune Disease Therapeutics Market, by Geography
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. EUROPE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION
3.1 Europe Rheumatic Disease Market by Country
3.2 Europe Diabetes Market by Country
3.3 Europe Multiple Sclerosis Market by Country
3.4 Europe Inflammatory Bowel Disease Market by Country
3.5 Europe Other Indications Market by Country
CHAPTER 4. EUROPE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS
4.1 Europe Anti-Inflammatory Market by Country
4.2 Europe Anti-Hyperglycemics Market by Country
4.3 Europe NSAIDs Market by Country
4.4 Europe Interferons Market by Country
4.5 Europe Other Drugs Market by Country
CHAPTER 5. EUROPE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL
5.1 Europe Hospital Pharmacy Market by Country
5.2 Europe Online Market by Country
5.3 Europe Retail Pharmacies and Drug Stores Market by Country
CHAPTER 6. EUROPE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY COUNTRY
6.1 Germany Autoimmune Disease Therapeutics Market
6.1.1 Germany Autoimmune Disease Therapeutics Market by Indication
6.1.2 Germany Autoimmune Disease Therapeutics Market by Drug Class
6.1.3 Germany Autoimmune Disease Therapeutics Market by Distribution Channel
6.2 UK Autoimmune Disease Therapeutics Market
6.2.1 UK Autoimmune Disease Therapeutics Market by Indication
6.2.2 UK Autoimmune Disease Therapeutics Market by Drug Class
6.2.3 UK Autoimmune Disease Therapeutics Market by Distribution Channel
6.3 France Autoimmune Disease Therapeutics Market
6.3.1 France Autoimmune Disease Therapeutics Market by Indication
6.3.2 France Autoimmune Disease Therapeutics Market by Drug Class
6.3.3 France Autoimmune Disease Therapeutics Market by Distribution Channel
6.4 Russia Autoimmune Disease Therapeutics Market
6.4.1 Russia Autoimmune Disease Therapeutics Market by Indication
6.4.2 Russia Autoimmune Disease Therapeutics Market by Drug Class
6.4.3 Russia Autoimmune Disease Therapeutics Market by Distribution Channel
6.5 Spain Autoimmune Disease Therapeutics Market
6.5.1 Spain Autoimmune Disease Therapeutics Market by Indication
6.5.2 Spain Autoimmune Disease Therapeutics Market by Drug Class
6.5.3 Spain Autoimmune Disease Therapeutics Market by Distribution Channel
6.6 Italy Autoimmune Disease Therapeutics Market
6.6.1 Italy Autoimmune Disease Therapeutics Market by Indication
6.6.2 Italy Autoimmune Disease Therapeutics Market by Drug Class
6.6.3 Italy Autoimmune Disease Therapeutics Market by Distribution Channel
6.7 Rest of Europe Autoimmune Disease Therapeutics Market
6.7.1 Rest of Europe Autoimmune Disease Therapeutics Market by Indication
6.7.2 Rest of Europe Autoimmune Disease Therapeutics Market by Drug Class
6.7.3 Rest of Europe Autoimmune Disease Therapeutics Market by Distribution Channel
CHAPTER 7. COMPANY PROFILES
7.1 ABBOTT Laboratories
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.2 Bio-Rad Laboratories, Inc.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expenses
7.3 Johnson and Johnson
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental &Regional Analysis
7.3.4 Research & Development Expenses
7.3.1 Recent strategies and developments:
7.3.1.1 Collaborations, partnerships and agreements:
7.4 GlaxoSmithKline PLC (GSK)
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.4.5 Recent strategies and developments:
7.4.5.1 Acquisition and mergers:
7.4.5.2 Collaborations, partnerships and agreements:
7.4.5.3 Product launches:
7.5 Pfizer, Inc.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.5.5 Recent strategies and developments:
7.5.5.1 Collaborations, partnerships and agreements:
7.5.5.2 Approval:
7.6 Merck & Co., Inc.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expenses
7.6.5 Recent strategies and developments:
7.6.5.1 Collaborations, partnerships and agreements:
7.6.5.2 Acquisition and mergers:
7.7 Bayer AG (Bayer Schering Pharma AG)
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expense
7.7.5 Recent strategies and developments:
7.7.5.1 Collaborations, partnerships and agreements:
7.8 AbbVie, Inc.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Regional Analysis
7.8.4 Research & Development Expense
7.8.5 Recent strategies and developments:
7.8.5.1 Collaborations, partnerships and agreements:
7.9 Amgen, Inc.
7.9.1 Company overview
7.9.2 Financial Analysis
7.9.3 Regional Analysis
7.9.4 Research & Development Expense
7.9.5 Recent strategies and developments:
7.9.5.1 Product launches:
7.9.5.2 Collaborations, partnerships and agreements:
7.1 Novartis AG
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research & Development Expense
7.10.5 Recent strategies and developments:
7.10.5.1 Acquisition and mergers:
7.10.5.2 Collaborations, partnerships and agreements:
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Autoimmune Disease Therapeutics Market, by Indication
1.4.2 Europe Autoimmune Disease Therapeutics Market, by Drug Class
1.4.3 Europe Autoimmune Disease Therapeutics Market, by Distribution Channel
1.4.4 Global Autoimmune Disease Therapeutics Market, by Geography
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. EUROPE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION
3.1 Europe Rheumatic Disease Market by Country
3.2 Europe Diabetes Market by Country
3.3 Europe Multiple Sclerosis Market by Country
3.4 Europe Inflammatory Bowel Disease Market by Country
3.5 Europe Other Indications Market by Country
CHAPTER 4. EUROPE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS
4.1 Europe Anti-Inflammatory Market by Country
4.2 Europe Anti-Hyperglycemics Market by Country
4.3 Europe NSAIDs Market by Country
4.4 Europe Interferons Market by Country
4.5 Europe Other Drugs Market by Country
CHAPTER 5. EUROPE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL
5.1 Europe Hospital Pharmacy Market by Country
5.2 Europe Online Market by Country
5.3 Europe Retail Pharmacies and Drug Stores Market by Country
CHAPTER 6. EUROPE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY COUNTRY
6.1 Germany Autoimmune Disease Therapeutics Market
6.1.1 Germany Autoimmune Disease Therapeutics Market by Indication
6.1.2 Germany Autoimmune Disease Therapeutics Market by Drug Class
6.1.3 Germany Autoimmune Disease Therapeutics Market by Distribution Channel
6.2 UK Autoimmune Disease Therapeutics Market
6.2.1 UK Autoimmune Disease Therapeutics Market by Indication
6.2.2 UK Autoimmune Disease Therapeutics Market by Drug Class
6.2.3 UK Autoimmune Disease Therapeutics Market by Distribution Channel
6.3 France Autoimmune Disease Therapeutics Market
6.3.1 France Autoimmune Disease Therapeutics Market by Indication
6.3.2 France Autoimmune Disease Therapeutics Market by Drug Class
6.3.3 France Autoimmune Disease Therapeutics Market by Distribution Channel
6.4 Russia Autoimmune Disease Therapeutics Market
6.4.1 Russia Autoimmune Disease Therapeutics Market by Indication
6.4.2 Russia Autoimmune Disease Therapeutics Market by Drug Class
6.4.3 Russia Autoimmune Disease Therapeutics Market by Distribution Channel
6.5 Spain Autoimmune Disease Therapeutics Market
6.5.1 Spain Autoimmune Disease Therapeutics Market by Indication
6.5.2 Spain Autoimmune Disease Therapeutics Market by Drug Class
6.5.3 Spain Autoimmune Disease Therapeutics Market by Distribution Channel
6.6 Italy Autoimmune Disease Therapeutics Market
6.6.1 Italy Autoimmune Disease Therapeutics Market by Indication
6.6.2 Italy Autoimmune Disease Therapeutics Market by Drug Class
6.6.3 Italy Autoimmune Disease Therapeutics Market by Distribution Channel
6.7 Rest of Europe Autoimmune Disease Therapeutics Market
6.7.1 Rest of Europe Autoimmune Disease Therapeutics Market by Indication
6.7.2 Rest of Europe Autoimmune Disease Therapeutics Market by Drug Class
6.7.3 Rest of Europe Autoimmune Disease Therapeutics Market by Distribution Channel
CHAPTER 7. COMPANY PROFILES
7.1 ABBOTT Laboratories
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.2 Bio-Rad Laboratories, Inc.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expenses
7.3 Johnson and Johnson
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental &Regional Analysis
7.3.4 Research & Development Expenses
7.3.1 Recent strategies and developments:
7.3.1.1 Collaborations, partnerships and agreements:
7.4 GlaxoSmithKline PLC (GSK)
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.4.5 Recent strategies and developments:
7.4.5.1 Acquisition and mergers:
7.4.5.2 Collaborations, partnerships and agreements:
7.4.5.3 Product launches:
7.5 Pfizer, Inc.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.5.5 Recent strategies and developments:
7.5.5.1 Collaborations, partnerships and agreements:
7.5.5.2 Approval:
7.6 Merck & Co., Inc.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expenses
7.6.5 Recent strategies and developments:
7.6.5.1 Collaborations, partnerships and agreements:
7.6.5.2 Acquisition and mergers:
7.7 Bayer AG (Bayer Schering Pharma AG)
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expense
7.7.5 Recent strategies and developments:
7.7.5.1 Collaborations, partnerships and agreements:
7.8 AbbVie, Inc.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Regional Analysis
7.8.4 Research & Development Expense
7.8.5 Recent strategies and developments:
7.8.5.1 Collaborations, partnerships and agreements:
7.9 Amgen, Inc.
7.9.1 Company overview
7.9.2 Financial Analysis
7.9.3 Regional Analysis
7.9.4 Research & Development Expense
7.9.5 Recent strategies and developments:
7.9.5.1 Product launches:
7.9.5.2 Collaborations, partnerships and agreements:
7.1 Novartis AG
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research & Development Expense
7.10.5 Recent strategies and developments:
7.10.5.1 Acquisition and mergers:
7.10.5.2 Collaborations, partnerships and agreements:
LIST OF TABLES
TABLE 1 EUROPE AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
TABLE 2 EUROPE AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
TABLE 3 EUROPE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
TABLE 4 EUROPE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
TABLE 5 EUROPE RHEUMATIC DISEASE MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 6 EUROPE RHEUMATIC DISEASE MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 7 EUROPE DIABETES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 8 EUROPE DIABETES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 9 EUROPE MULTIPLE SCLEROSIS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 10 EUROPE MULTIPLE SCLEROSIS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 11 EUROPE INFLAMMATORY BOWEL DISEASE MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 12 EUROPE INFLAMMATORY BOWEL DISEASE MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 13 EUROPE OTHER INDICATIONS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 14 EUROPE OTHER INDICATIONS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 15 EUROPE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
TABLE 16 EUROPE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
TABLE 17 EUROPE ANTI-INFLAMMATORY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 18 EUROPE ANTI-INFLAMMATORY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 19 EUROPE ANTI-HYPERGLYCEMICS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 20 EUROPE ANTI-HYPERGLYCEMICS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 21 EUROPE NSAIDS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 22 EUROPE NSAIDS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 23 EUROPE INTERFERONS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 24 EUROPE INTERFERONS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 25 EUROPE OTHER DRUGS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 26 EUROPE OTHER DRUGS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 27 EUROPE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 28 EUROPE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 29 EUROPE HOSPITAL PHARMACY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 30 EUROPE HOSPITAL PHARMACY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 31 EUROPE ONLINE MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 32 EUROPE ONLINE MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 33 EUROPE RETAIL PHARMACIES AND DRUG STORES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 34 EUROPE RETAIL PHARMACIES AND DRUG STORES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 35 EUROPE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 36 EUROPE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 37 GERMANY AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
TABLE 38 GERMANY AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
TABLE 39 GERMANY AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
TABLE 40 GERMANY AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
TABLE 41 GERMANY AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
TABLE 42 GERMANY AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
TABLE 43 GERMANY AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 44 GERMANY AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 45 UK AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
TABLE 46 UK AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
TABLE 47 UK AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
TABLE 48 UK AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
TABLE 49 UK AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
TABLE 50 UK AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
TABLE 51 UK AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 52 UK AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 53 FRANCE AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
TABLE 54 FRANCE AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
TABLE 55 FRANCE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
TABLE 56 FRANCE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
TABLE 57 FRANCE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
TABLE 58 FRANCE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
TABLE 59 FRANCE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 60 FRANCE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 61 RUSSIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
TABLE 62 RUSSIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
TABLE 63 RUSSIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
TABLE 64 RUSSIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
TABLE 65 RUSSIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
TABLE 66 RUSSIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
TABLE 67 RUSSIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 68 RUSSIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 69 SPAIN AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
TABLE 70 SPAIN AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
TABLE 71 SPAIN AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
TABLE 72 SPAIN AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
TABLE 73 SPAIN AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
TABLE 74 SPAIN AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
TABLE 75 SPAIN AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 76 SPAIN AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 77 ITALY AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
TABLE 78 ITALY AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
TABLE 79 ITALY AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
TABLE 80 ITALY AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
TABLE 81 ITALY AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
TABLE 82 ITALY AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
TABLE 83 ITALY AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 84 ITALY AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 85 REST OF EUROPE AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
TABLE 86 REST OF EUROPE AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
TABLE 87 REST OF EUROPE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
TABLE 88 REST OF EUROPE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
TABLE 89 REST OF EUROPE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
TABLE 90 REST OF EUROPE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
TABLE 91 REST OF EUROPE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 92 REST OF EUROPE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 93 KEY INFORMATION – ABBOTT LABORATORIES
TABLE 94 KEY INFORMATION – BIO-RAD LABORATORIES, INC.
TABLE 95 KEY INFORMATION –JOHNSON AND JOHNSON
TABLE 96 KEY INFORMATION – GLAXOSMITHKLINE PLC (GSK)
TABLE 97 KEY INFORMATION – PFIZER, INC.
TABLE 98 KEY INFORMATION – MERCK & CO., INC.
TABLE 99 KEY INFORMATION – BAYER AG
TABLE 100 KEY INFORMATION – ABBVIE, INC.
TABLE 101 KEY INFORMATION – AMGEN, INC.
TABLE 102 KEY INFORMATION – NOVARTIS AG
TABLE 1 EUROPE AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
TABLE 2 EUROPE AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
TABLE 3 EUROPE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
TABLE 4 EUROPE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
TABLE 5 EUROPE RHEUMATIC DISEASE MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 6 EUROPE RHEUMATIC DISEASE MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 7 EUROPE DIABETES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 8 EUROPE DIABETES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 9 EUROPE MULTIPLE SCLEROSIS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 10 EUROPE MULTIPLE SCLEROSIS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 11 EUROPE INFLAMMATORY BOWEL DISEASE MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 12 EUROPE INFLAMMATORY BOWEL DISEASE MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 13 EUROPE OTHER INDICATIONS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 14 EUROPE OTHER INDICATIONS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 15 EUROPE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
TABLE 16 EUROPE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
TABLE 17 EUROPE ANTI-INFLAMMATORY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 18 EUROPE ANTI-INFLAMMATORY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 19 EUROPE ANTI-HYPERGLYCEMICS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 20 EUROPE ANTI-HYPERGLYCEMICS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 21 EUROPE NSAIDS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 22 EUROPE NSAIDS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 23 EUROPE INTERFERONS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 24 EUROPE INTERFERONS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 25 EUROPE OTHER DRUGS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 26 EUROPE OTHER DRUGS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 27 EUROPE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 28 EUROPE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 29 EUROPE HOSPITAL PHARMACY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 30 EUROPE HOSPITAL PHARMACY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 31 EUROPE ONLINE MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 32 EUROPE ONLINE MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 33 EUROPE RETAIL PHARMACIES AND DRUG STORES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 34 EUROPE RETAIL PHARMACIES AND DRUG STORES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 35 EUROPE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 36 EUROPE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 37 GERMANY AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
TABLE 38 GERMANY AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
TABLE 39 GERMANY AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
TABLE 40 GERMANY AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
TABLE 41 GERMANY AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
TABLE 42 GERMANY AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
TABLE 43 GERMANY AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 44 GERMANY AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 45 UK AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
TABLE 46 UK AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
TABLE 47 UK AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
TABLE 48 UK AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
TABLE 49 UK AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
TABLE 50 UK AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
TABLE 51 UK AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 52 UK AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 53 FRANCE AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
TABLE 54 FRANCE AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
TABLE 55 FRANCE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
TABLE 56 FRANCE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
TABLE 57 FRANCE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
TABLE 58 FRANCE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
TABLE 59 FRANCE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 60 FRANCE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 61 RUSSIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
TABLE 62 RUSSIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
TABLE 63 RUSSIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
TABLE 64 RUSSIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
TABLE 65 RUSSIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
TABLE 66 RUSSIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
TABLE 67 RUSSIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 68 RUSSIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 69 SPAIN AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
TABLE 70 SPAIN AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
TABLE 71 SPAIN AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
TABLE 72 SPAIN AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
TABLE 73 SPAIN AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
TABLE 74 SPAIN AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
TABLE 75 SPAIN AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 76 SPAIN AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 77 ITALY AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
TABLE 78 ITALY AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
TABLE 79 ITALY AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
TABLE 80 ITALY AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
TABLE 81 ITALY AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
TABLE 82 ITALY AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
TABLE 83 ITALY AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 84 ITALY AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 85 REST OF EUROPE AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
TABLE 86 REST OF EUROPE AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
TABLE 87 REST OF EUROPE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
TABLE 88 REST OF EUROPE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
TABLE 89 REST OF EUROPE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
TABLE 90 REST OF EUROPE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
TABLE 91 REST OF EUROPE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 92 REST OF EUROPE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 93 KEY INFORMATION – ABBOTT LABORATORIES
TABLE 94 KEY INFORMATION – BIO-RAD LABORATORIES, INC.
TABLE 95 KEY INFORMATION –JOHNSON AND JOHNSON
TABLE 96 KEY INFORMATION – GLAXOSMITHKLINE PLC (GSK)
TABLE 97 KEY INFORMATION – PFIZER, INC.
TABLE 98 KEY INFORMATION – MERCK & CO., INC.
TABLE 99 KEY INFORMATION – BAYER AG
TABLE 100 KEY INFORMATION – ABBVIE, INC.
TABLE 101 KEY INFORMATION – AMGEN, INC.
TABLE 102 KEY INFORMATION – NOVARTIS AG
LIST OF FIGURES
FIG 1 METHODOLOGY FOR THE RESEARCH
FIG 1 METHODOLOGY FOR THE RESEARCH
